Skip to Main Content

Paper Details

Anti-trypanosomatid structure-based drug design - lessons learned from targeting the folate pathway.
Expert Opin Drug Discov
5
2022
Trypanosomatidic parasitic infections, folate, humans, trypanosomatid, trypanosomatid-borne diseases
Author NameAffiliation
Rebecca C WadeCenter for Molecular Biology (ZMBH), Heidelberg University
Rebecca C WadeHeidelberg Institute for Theoretical Studies (HITS)
Rebecca C WadeDKFZ-ZMBH Alliance and Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University
Rebecca C WadeCenter for Molecular Biology (ZMBH), Heidelberg University
Rebecca C WadeHeidelberg Institute for Theoretical Studies (HITS)
Rebecca C WadeDKFZ-ZMBH Alliance and Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University
  • 1 - 6

Datasets

PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink